Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Oral and parenteral administration of aztreonam and oral administration of tigemonam to conventional mice caused a decrease in the number of aerobic gram-negative rods in the feces. Oral treatment with high doses of aztreonam (≥25 mg/kg/day) and tigemonam (100 mg/kg/day) adversely influenced colonization resistance, whereas oral treatment with lower doses of the monobactams or parenteral treatment with aztreonam did not.

Cite

CITATION STYLE

APA

Van Ogtrop, M. L., Guiot, H. F. L., Mattie, H., Van Strijen, E., Razab Sekh, B., & Van Furth, R. (1991). Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam. Antimicrobial Agents and Chemotherapy, 35(5), 983–985. https://doi.org/10.1128/AAC.35.5.983

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free